Retatrutide vs glp2 and glp1

by | Sep 11, 2025 | Retatrutide, GLP1/Glp1S, GLP2/GLP2T, Peptide Research

Retatrutide vs. GLP-2/GLP2t vs. GLP-1/GLP1s: The Battle of the Agonists

In the rapidly evolving world of metabolic research, three peptides currently dominate the conversation: GLP-1/GLP1s, GLP-2/GLP2t, and the newcomer, Retatrutide. While all three share similarities, their mechanisms of action differ significantly.

At BulkGLP, we provide high-purity research peptides to help you explore these differences. This guide breaks down the "Single," "Dual," and "Triple" agonist mechanisms that define these compounds.

The Core Difference: Receptor Targets

The primary difference lies in how many hormone receptors each peptide activates. This is often referred to as the "G" count.

  • GLP-1/GLP1s (1G): Targets only the GLP-1 receptor.
  • GLP-2/GLP2t (2G): Targets both GLP-1 and GIP receptors.
  • Retatrutide (3G): Targets GLP-1, GIP, and the Glucagon receptor.

Researching the Triple Agonist?

Retatrutide is currently the only "Triple G" peptide available for research. Its addition of Glucagon agonism makes it unique in metabolic studies.

View Retatrutide Products

Comparison Table: Mechanisms of Action

Feature GLP-1/GLP1s GLP-2/GLP2t Retatrutide
GLP-1 Agonism
(Appetite Suppression)		 Yes Yes Yes
GIP Agonism
(Insulin Sensitivity)		 No Yes Yes
Glucagon Agonism
(Energy Expenditure)		 No No Yes
Research Status Established Established Emerging / Novel

1. GLP-1/GLP1s: The Standard

GLP-1/GLP1s is a modified version of the GLP-1 hormone. It has been the gold standard in research for years. It works primarily by slowing gastric emptying and signaling satiety centers in the brain.

Related Research: View GLP-1/GLP1s Options

2. GLP-2/GLP2t: The Dual Agonist

GLP-2/GLP2t built upon the success of GLP-1/GLP1s by adding GIP (Glucose-dependent Insulinotropic Polypeptide) receptor activity. Research suggests GIP may work synergistically with GLP-1 to improve lipid metabolism and insulin sensitivity without the nausea often associated with high-dose GLP-1 mono-agonists.

Related Research: View GLP-2/GLP2t Options

3. Retatrutide: The Triple Threat

Retatrutide (LY3437943) introduces a third mechanism: Glucagon. While Glucagon is traditionally known for raising blood sugar, activating its receptor in combination with GLP-1 and GIP appears to increase energy expenditure (calorie burning) and improve liver health in animal models.

Why Glucagon Matters

By stimulating the glucagon receptor, Retatrutide may enhance mitochondrial function and lipid oxidation. This "thermogenic" effect is what separates it from GLP-2/GLP2t.

Ready to compare in your lab?

We stock high-purity lyophilized powders of all three peptides for comparative research.

Browse All Peptides

Get 10% Off Your Order!

Join our list and get an instant discount code.

You're In!

Use this code at checkout:

Get 10% Off
Get 10% Off
Quick Verification
Research Supply Site

To continue, please confirm the following:

By continuing, you acknowledge and agree to the statements above. View terms

0

Terms & Conditions

Last updated: September 23, 2025

These Terms & Conditions (“Terms”) govern your use of bulkglp.com and your purchase/use of our products and services (the “Services”). By using the Services, you agree to these Terms.

1. Research Use Only

All products are intended strictly for laboratory research by qualified individuals/entities. Products are not for human or veterinary use, ingestion, injection, diagnostic, therapeutic, or household use.

2. Eligibility & Compliance

  • You are at least 18 years old (or older where required) and legally able to enter contracts.
  • You purchase for legitimate research and will comply with applicable laws/regulations.
  • You will follow appropriate lab safety, handling, storage, and disposal protocols.

3. Research-Use Certification

By ordering, you certify you understand hazards/handling, are qualified to use these materials, will not use them for human/animal applications, and will not resell in violation of these Terms or law.

4. No Medical Advice; No FDA Evaluation

Site content is for research/educational purposes only. Statements are not evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease.

5. Orders, Pricing, Availability

  • Orders are offers to buy; acceptance occurs when we dispatch goods.
  • Prices/descriptions/availability may change without notice; errors may be corrected at any time.
  • We may impose quantity limits or require additional verification prior to shipment.

6. Payment & Fraud

You authorize charges to your selected payment method, including shipping and taxes. We use risk tools and may request additional information; unverifiable orders may be canceled.

7. Shipping, Risk of Loss, Customs

Title and risk of loss transfer upon carrier acceptance. Inspect upon delivery and retain materials for any claim. Delivery estimates are not guarantees; carrier delays are outside our control. International buyers are responsible for import compliance, duties, and taxes.

8. Returns & Refunds

See our Refund Policy. Due to sterility and chain-of-custody, reconstituted, opened, or punctured vials cannot be returned or refunded.

9. Product Handling, Safety & COAs

Products may pose hazards if mishandled. Use only in controlled lab environments with appropriate PPE. Certificates of Analysis (COAs) may be provided on the Site or with products.

10. Intellectual Property

All Site content (text, graphics, logos, images, data, and code) is owned by BulkGLP or its licensors. You may not copy, modify, distribute, or create derivative works without prior written consent.

11. Acceptable Use

No scraping, reverse engineering, security probing, spam, or interference. No use that violates laws, infringes rights, or facilitates illegal activity.

12. Disclaimers

TO THE MAXIMUM EXTENT PERMITTED BY LAW, THE SERVICES AND PRODUCTS ARE PROVIDED “AS IS” AND “AS AVAILABLE,” WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT. RESEARCH MATERIALS MAY BE EXPERIMENTAL AND INVOLVE RISKS.

13. Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW, BULKGLP AND ITS OFFICERS, DIRECTORS, EMPLOYEES, AND AGENTS WILL NOT BE LIABLE FOR INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, EXEMPLARY, OR PUNITIVE DAMAGES, OR ANY LOSS OF PROFITS, REVENUE, DATA, OR GOODWILL. OUR TOTAL LIABILITY FOR ANY CLAIM WILL NOT EXCEED THE AMOUNT YOU PAID FOR THE PRODUCT AT ISSUE.

14. Indemnification

You agree to indemnify and hold harmless BulkGLP from claims, losses, liabilities, damages, costs, and expenses (including reasonable attorneys’ fees) arising out of your use/misuse of products or the Services, your violation of these Terms, or any law/right of a third party.

15. Dispute Resolution; Arbitration; Class-Action Waiver

  • Governing Law: Texas law (without regard to conflicts principles).
  • Arbitration: Any dispute relating to these Terms or the products will be resolved by binding arbitration in Dallas County, Texas. Judgment on the award may be entered in any court of competent jurisdiction.
  • Class-Action Waiver: Disputes must be brought individually, not as a class or representative action.

16. Changes

We may update these Terms at any time. The “Last updated” date reflects the latest version. Continued use after changes are effective constitutes acceptance.

17. Contact

For questions regarding these Terms, contact us:
Email: support@bulkglp.com
Postal: BulkGLP, Dallas, TX, USA